Aytu Biopharma (AYTU) Total Debt Growth (3y) (2015 - 2026)
Aytu Biopharma (AYTU) Total Debt Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 92.16 Bn | 90.29 Bn | - | -2.21% |
| 2 | Teva Pharmaceutical Industries | 36.38 Bn | 32.64 Bn | 1.97 Bn | -7.03% |
| 3 | Zoetis | 32.90 Bn | 30.96 Bn | 1.62 Bn | 11.29% |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | 63.29% |
| 5 | United Therapeutics | 22.82 Bn | 20.66 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.75 Bn | 22.75 Bn | - | - |
| 7 | Viatris | 20.58 Bn | 18.78 Bn | 1.16 Bn | -7.76% |
| 8 | Neurocrine Biosciences | 18.26 Bn | 16.94 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.76 Bn | 12.33 Bn | 785.00 Mn | -14.15% |
| 10 | Aytu Biopharma | 22.50 Mn | -4.22 Mn | 7.60 Mn | -8.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.09% |
| Dec 31, 2025 | 9.26% |
| Sep 30, 2025 | -18.92% |
| Jun 30, 2025 | 3.33% |
| Mar 31, 2025 | -7.23% |
| Dec 31, 2024 | 106.99% |
| Sep 30, 2024 | 46.51% |
| Jun 30, 2024 | -7.64% |
| Mar 31, 2024 | -53.96% |
| Dec 31, 2023 | 5.44% |
| Sep 30, 2023 | 8.68% |
| Jun 30, 2023 | 154.96% |
| Mar 31, 2023 | -16.85% |
| Dec 31, 2022 | -15.34% |
| Sep 30, 2022 | 165.28% |
| Mar 31, 2022 | 33.89% |
| Dec 31, 2021 | -38.10% |
| Sep 30, 2021 | 165.54% |
| Jun 30, 2021 | 213.44% |
| Mar 19, 2021 | 715.30% |